IPNews® – Humanetics announced that after years of research and development with Mount Sinai Medical School, it has been granted a patent for its Alzheimer’s disease treatment.
The newly patented compound NIC5-15 includes methodology for preventing the formation of beta-amyloid plaques, which is widely believed to be the leading cause of Alzheimer’s disease. The Minnesota
IPNews® – Texas based Interphase announced today that it was awarded a patent for Penveu, its latest interactive display system technology.
Intended to enhance collaboration between users of whiteboards and audiences, the newly patented product is small enough to fit into a pocket and accurate to a single pixel. Penveu is also compatible with any
IPNews® – Intel recently purchased 1,700 patents from InterDigital to add to its wireless technology patent portfolio.
The move apparently helps InterDigital as it had been rumored to be near closing its doors. With regard to Intel, the patents help position it as a new player in the cell phone industry. To continue reading, click:
IPNews® – Monsanto sued its competitor DuPont in Missouri district court this week for infringement of its seed chipping technology.
A vital process in crop development, seed chipping is the system of automating samples of material from seeds, while allowing them to be planted later. Monsanto is asking for a court order to prevent Dupont
IPNews® – Apple recently announced that it has been granted a patent for its online identity cloning technology.
The new patent covers online methods that intentionally pollute a user’s online profile by gathering data, creating fake areas of interest, and performing periodic actions on a network at regular intervals and randomly selecting actions to perform.
IPNews® – High Roads announced today that it has been granted a patent for its healthcare benchmarking technology.
The newly patented invention, called The Lab, was created in response to gross inefficiencies in human resources departments. High Roads’ latest healthcare software is designed to help companies compare plans by price, company size, industry and geography.
IPNews® – Prescription giant Merck announced today that it lost its recent patent infringement battle against Canadian competitor Apotex.
The Canadian company had been accused of illegally selling a copy of Merck’s popular nasal allergy drug Nasonex. Rather than strictly denying the allegations, Apotex challenged the validity of the Nasonex patent. To continue reading, click:
IPNews® – Kodak has recently lost its patent infringement case against Apple and RIM.
Currently in the middle of Chapter 11 bankruptcy proceedings, the digital imaging company had hoped for a settlement and to force its two rivals to pay licensing fees. Though initially disheartening for the struggling company, the outcome of the case is
IPNews® – Mountain View Pharmaceuticals (MVP) has been granted a European Patent titled “Polyethylene Glycol Conjugates of Interferon-beta-1b with Enhanced in vitro Biological Potency.”
The patent aims to aid in the reduction of cases in which patients with multiple sclerosis suffer from a relapse. It adds to MVP’s portfolio of 170 worldwide patents. To continue
IPNews® – A patent was issued last week to economics professor Joseph Henry Vogel for a system and method for controlling use of academic texts.
Patent 8,195,571 requires students to participate in a web-based online discussion board, which would count toward their final course grade. The code to gain access to the discussion board would